文献速递关节外科

55岁及以下患者无菌性全髋关节翻修术后的生存率与再翻修危险因素

Survivorship and Risk Factors for Re-Revision after Aseptic Revision Total Hip Arthroplasty in Patients Aged ≤55 Years.
PubMed 文献 · J Arthroplasty · 2022-03-19

本研究纳入354例平均年龄48岁、平均随访5年的无菌性非肿瘤性全髋关节翻修术患者,18%在平均2.5年时接受再翻修,最常见原因为不稳定(37%)。5年无全因再翻修生存率为83%,仅股骨假体翻修(HR 4.8,P=.014)和头/内衬更换(HR 2.5,P=.022)是再翻修的危险因素。

要点

  • 55岁及以下患者全髋翻修术后5年无再翻修生存率为83%,无再手术生存率为79%。
  • 18%的患者在平均2.5年时接受再翻修,最常见原因为不稳定(37%)。
  • 仅股骨假体翻修(HR 4.8,P=.014)和头/内衬更换(HR 2.5,P=.022)是再翻修的危险因素。

核心结论

  • 约五分之一的55岁及以下全髋翻修术患者5年内需再翻修,最常见原因为不稳定。
  • 再翻修风险最高的组包括接受头/内衬更换和孤立股骨假体翻修的患者。

研究设计与样本

  • 回顾性识别354例接受无菌性非肿瘤性全髋关节翻修术的患者,翻修术后平均随访5年。
  • 患者平均年龄48岁,平均体重指数28 kg/m2,64%为女性,35例(10%)既往至少接受过1次全髋翻修术。
  • 采用Kaplan-Meier法测量无再翻修生存率,多因素回归分析再翻修危险因素。

主要发现

  • 62例(18%)接受再翻修全髋关节置换术,平均时间2.5年,最常见原因为不稳定(37%)、无菌性松动(27%)和假体周围关节感染(15%)。
  • 全因再翻修和再手术的5年生存率分别为83%和79%。
  • 多因素分析显示,仅股骨假体翻修(风险比4.8,P=.014)和头/内衬更换翻修(风险比2.5,P=.022)是再翻修全髋关节置换术的危险因素。

关键数值与推荐

  • 翻修主要指征包括磨损/骨溶解(21%)、不良局部组织反应(21%)、复发性不稳定(20%)、髋臼松动(16%)和股骨松动(7%)。
  • 翻修类型包括仅髋臼假体翻修149例(42%)、仅股骨假体翻修46例(13%)、髋臼和股骨假体均翻修44例(12%)、头/内衬更换115例(33%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a relative paucity of literature on the outcomes after revision total hip arthroplasty (rTHA) in young patients. This study reports the survivorship and risk factors for re-revision in patients aged ≤55 years. METHODS: We identified 354 patients undergoing aseptic nononcologic rTHA at mean follow-up of 5 years after revision, with mean age of 48 years, body mass index of 28 kg/m2, and 64% female. Thirty-five (10%) patients underwent at least 1 previous rTHA. The main indications for rTHA included wear/osteolysis (21%), adverse local tissue reaction (21%), recurrent instability (20%), acetabular loosening (16%), and femoral loosening (7%); and included acetabular component-only rTHA in 149 patients (42%), femoral component-only rTHA in 46 patients (13%), both component rTHA in 44 patients (12%), and head/liner exchanges in patients 115 (33%). The Kaplan-Meier method was used to measure survivorship free from re-revision THA, and multivariate regression was used to identify risk factors for re-revision THA. RESULTS: Sixty-two patients (18%) underwent re-revision THA at the mean time of 2.5 years, most commonly for instability (37%), aseptic loosening (27%), and prosthetic joint infection (15%). The rTHA survivorship from all-cause re-revision and reoperation was 83% and 79% at 5 years, respectively. Multivariate analysis demonstrated that patients undergoing femoral component only (hazard ratio 4.8, P = .014) and head/liner exchange rTHA (hazard ratio 2.5, P = .022) as risk factors for re-revision THA. CONCLUSION: About 1 in 5 patients aged ≤55 years undergoing rTHA required re-revision THA at 5 years, most commonly for instability. The highest risk group included patients undergoing head/liner exchanges and isolated femoral component revisions.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Sarpong NO, Kaidi AC, Syku M, et al. Survivorship and Risk Factors for Re-Revision after Aseptic Revision Total Hip Arthroplasty in Patients Aged ≤55 Years. J Arthroplasty. 2022. PMID: 35318097. doi:10.1016/j.arth.2022.03.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。